El interés en corto de GDS Holdings da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de GDS Holdings. Los datos de interés en corto se actualizan cada dos semanas.

GDS Holdings (NASDAQ:GDS) Bolsa, Informe de interés en corto

GDS HOLDINGS LTD - ADR

GDS Holdings

GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. It has aggressively raised capital over the past four years for expansion. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.

GDS Holdings Limited - American Depositary Shares

GDS Holdings Ltd

GLOBAL DIGITAL SLTNS INC by Global Digital Solutions, Inc.

Global Digital Solutions Inc

Nevada Zinc Corp

GOLDENSTONE ACQ LTD by Goldenstone Acquisition Limited

Goldenstone Acquisition Ltd

GOLDENSTONE ACQUISITION LTD RT

Goldenstone Acquisition Ltd Units (1 Ord , 1 War & 1 Rts)

Goldenstone Acquisition Ltd Warrants (15/07/2026)

Profound Medical (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PRN#TSX">PRN</a>) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.40) by 10 percent. This is a 33.33 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $2.62 million which missed the analyst consensus estimate of $6.55 million by 59.98 percent. This is a 82.14 percent increase over sales of $1.44 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

TSX:PRN

Profound Medical Q1 GAAP EPS $(0.36) Beats $(0.40) Estimate, Sales $2.62M Miss $6.55M Estimate

DocGo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCGO#NASDAQ">DCGO</a>) lowers FY2025 sales outlook from $410.00 million-$450.00 million to $300.00 million-$330.00 million.

Guidance

DCGO

DocGo Lowers FY2025 Sales Guidance from $410.00M-$450.00M to $300.00M-$330.00M

WIIM

ILMN

Illumina shares are trading lower after the company reported Q1 financial results and cut its FY25 adjusted EPS guidance below estimates.

HealthStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>), a leading healthcare technology platform company for workforce solutions, today announced that its Board of Directors has approved a new share repurchase program for the Company's common stock, under which the Company may repurchase up to $25 million of outstanding shares of common stock.
Pursuant to the authorization, repurchases may be made from time to time in the open market, including under a Rule 10b5-1 plan, through privately negotiated transactions, or otherwise. In addition, any repurchases under the authorization will be subject to prevailing market conditions, liquidity and cash flow considerations, applicable securities laws requirements (including under Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as applicable), and other factors. The share repurchase program will terminate on the earlier of May 31, 2026 or when the maximum dollar amount has been expended. The share repurchase program does not require the Company to acquire any amount of shares and may be suspended or discontinued at any time.

Offerings

HSTM

HealthStream Announces Share Repurchase Program Of Up $25M Of Outstanding Shares Of Common Stock

Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.65 by 9.23 percent. This is a 118.52 percent increase over earnings of $0.27 per share from the same period last year. The company reported $538.60 million in sales this quarter. This is a 1.51 percent increase over sales of $530.60 million the same period last year.

Valhi Q1 EPS $0.59 Misses $0.65 Estimate, Sales $538.60M Up From $530.60M YoY

Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) affirms FY2025 Adj EPS guidance from $(0.01)-$0.07 to $(0.01)-$0.07 vs $0.03 analyst estimate. Affirms FY2025 sales outlook from $1.30 billion-$1.37 billion to $1.30 billion-$1.37 billion vs $1.34 billion estimate.

LESL

Leslies Affirms FY2025 Adj EPS Guidance of $(0.01)-$0.07 vs $0.03 Est; Affirms FY2025 Sales Guidance of $1.30B-$1.37B vs $1.34B Est

Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by 200 percent. This is a 93.33 percent decrease over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $1.45 billion which missed the analyst consensus estimate of $1.47 billion by 1.06 percent. This is a 13.53 percent increase over sales of $1.28 billion the same period last year.

LYFT

Lyft Q1 EPS $0.01 Beats $(0.01) Estimate, Sales $1.45B Miss $1.47B Estimate

Onto Innovation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>) is looking for Q2 Adj EPS of $1.21-$1.35 vs $1.50 analyst estimate. sees sales of $240.000 million-$260.000 million vs $269.10 million analyst estimate.

ONTO

Onto Innovation Sees Q2 Adj EPS $1.21-$1.35 vs $1.50 Est; Sees Sales $240.000M-$260.000M vs $269.10M Est

Green Dot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDOT#NYSE">GDOT</a>) reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $0.71 by 49.3 percent. This is a 79.66 percent increase over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $555.96 million which beat the analyst consensus estimate of $507.93 million by 9.46 percent. This is a 24.26 percent increase over sales of $447.42 million the same period last year.

GDOT

Green Dot Q1 Adj. EPS $1.06 Beats $0.71 Estimate, Sales $555.96M Beat $507.93M Estimate

DocGo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCGO#NASDAQ">DCGO</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.02) by 350 percent. This is a 190 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $96.03 million which missed the analyst consensus estimate of $104.25 million by 7.88 percent. This is a 50.01 percent decrease over sales of $192.09 million the same period last year.

DocGo Q1 EPS $(0.09) Misses $(0.02) Estimate, Sales $96.03M Miss $104.25M Estimate

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 600 percent. This is a 350 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $4.88 million which beat the analyst consensus estimate of $3.65 million by 33.56 percent. This is a 38.47 percent increase over sales of $3.52 million the same period last year.

NEPH

Nephros Q1 EPS $0.05 Beats $(0.01) Estimate, Sales $4.88M Beat $3.65M Estimate

Data I/O Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIO#NASDAQ">DAIO</a>), the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced recent open-market stock purchases by Company insiders. During the most recent trading window that opened following the Company's first quarter financial report, several insiders including Board members and senior management purchased Data I/O common stock, the details of which are disclosed as appropriate in Form 4 filings with the Securities and Exchange Commission.
William Wentworth, President/CEO and Executive Board Member of Data I/O Corporation, said, "I am encouraged by my fellow insiders joining me in making open-market purchases of the Company's common stock. These purchases underscore the confidence we have in delivering on our long-term strategic goals for driving market dominance, revenue growth and profitability. Although considerable progress was made in key operational areas and we delivered sequential growth despite global trade tensions in the first quarter, we believe recent prices for Data I/O common shares do not represent the inherent value of our business and future growth opportunities. The recent open-market purchases of our common stock should send a strong message that now, more than ever, we are aligned with all our shareholders and look forward to improved return on investment."

DAIO

Board Members And Executives Purchase Data I/O Shares Following Q1 Report

Alarm.com Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRM#NASDAQ">ALRM</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.48 by 12.5 percent. This is a 8 percent increase over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $238.82 million which beat the analyst consensus estimate of $234.82 million by 1.70 percent. This is a 6.96 percent increase over sales of $223.28 million the same period last year.

ALRM

Alarm.com Holdings Q1 Adj. EPS $0.54 Beats $0.48 Estimate, Sales $238.82M Beat $234.82M Estimate

DKNG

DraftKings shares are trading higher. The company announced a year-over-year increase in its Q1 monthly average users.

Crinetics Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>) reported quarterly losses of $(1.04) per share which missed the analyst consensus estimate of $(0.93) by 11.83 percent. This is a 11.83 percent decrease over losses of $(0.93) per share from the same period last year. The company reported quarterly sales of $361.00 thousand which beat the analyst consensus estimate of $90.91 thousand by 297.10 percent. This is a 43.59 percent decrease over sales of $640.00 thousand the same period last year.

CRNX

Crinetics Pharmaceuticals Q1 EPS $(1.04) Misses $(0.93) Estimate, Sales $361.00K Beat $90.91K Estimate

Onto Innovation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $1.47 by 2.72 percent. This is a 27.97 percent increase over earnings of $1.18 per share from the same period last year. The company reported quarterly sales of $267.00 million which beat the analyst consensus estimate of $266.30 million by 0.26 percent. This is a 16.67 percent increase over sales of $228.85 million the same period last year.

Onto Innovation Q1 Adj. EPS $1.51 Beats $1.47 Estimate, Sales $267.00M Beat $266.30M Estimate

SIGA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) reported quarterly losses of $(0.01) per share. This is a 107.14 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $7.04 million in sales this quarter. This is a 72.31 percent decrease over sales of $25.43 million the same period last year.

SIGA

SIGA Technologies Q1 EPS $(0.01) Down From $0.14 YoY, Sales $7.04M Down From $25.43M YoY

Financial Outlook Due to the ongoing macroeconomic uncertainty and the recent industry announcements regarding new game releases, the Company is revising its financial outlook for the full year 2025. The Company currently expects gaming accessories markets to improve throughout 2025 but remain down for the full year compared to 2024, resulting in Company net revenues in the range of $340 million and $360 million. As the Company continues to execute on its profitability initiatives, it currently expects Adjusted EBITDA to be between $47 million and $53 million.

TBCH

Turtle Beach Lowers FY2025 Sales Guidance from $395.00M-$405.00M to $340.00M-$360.00M vs $400.16M Est

Main Street Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAIN#NYSE">MAIN</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $1.01 by 5.94 percent. This is a 3.6 percent decrease over earnings of $1.11 per share from the same period last year.

MAIN

Main Street Capital Q1 Adj. EPS $1.07 Beats $1.01 Estimate

Beauty Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKIN#NASDAQ">SKIN</a>) affirms FY2025 sales outlook from $270.00 million-$300.00 million to $270.00 million-$300.00 million vs $288.46 million estimate.

SKIN

Beauty Health Affirms FY2025 Sales Guidance of $270.00M-$300.00M vs $288.46M Est

Press Releases

GDS Announces US$1.0 Billion Equity Raise By Its International Affiliate Led By Prestigious New US Investors

Legal

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of GDS Holdings Limited Publicly-Traded American Depositary Shares - GDS

GDS to Report Third Quarter 2024 Financial Results Before the Open of the U.S. Market on November 19, 2024

The Rosen Law Firm, P.A. Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of GDS Holdings Limited Publicly-Traded American Depositary Shares - GDS

Comments

GDS Holdings

Interés en corto

GDS Holdings (NASDAQ:GDS) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL